Bromley Laments Funding Shortfall

Bush's science adviser says he'd like to see government bolster financial support, urges more consideration for individual researchers WASHINGTON--The Bush administration wants to do more for "small science," says presidential science adviser D. Allan Bromley. But the type of support Bromley has in mind appears to be more psychological than financial. "The small investigator needs to have a feeling of being paid attention to," Bromley told The Scientist. "There's a feeling that the large proj

Written byJeffrey Mervis
| 19 min read

Register for free to listen to this article
Listen with Speechify
0:00
19:00
Share


Bush's science adviser says he'd like to see government bolster financial support, urges more consideration for individual researchers
WASHINGTON--The Bush administration wants to do more for "small science," says presidential science adviser D. Allan Bromley. But the type of support Bromley has in mind appears to be more psychological than financial.

"The small investigator needs to have a feeling of being paid attention to," Bromley told The Scientist. "There's a feeling that the large projects, like the genome project, the AIDS epidemic, and so on, have taken the focus away from the individual investigator. And I think that we can do something about that."

Bromley, on leave from his post as professor of physics at Yale University, outlined his strategy to help individual investigators in a wide-ranging, 90-minute interview held late last month in his ornate office across the street from the White House. He agreed that the National Institutes ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies